Dichloromethane → N-{2-[2-(2-Methoxy-4-piperidin-4-yl-phenylamino)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-7-yl]-phenyl}-N-methyl-methanesulfonamide
Reaction equation
O[C:2]1[N:7]=[CH:6][C:5]2=[C:8]([CH3:23])[CH:9]=[C:10]([C:11]3[CH:16]=[CH:15][CH:14]=[CH:13][C:12]=3[N:17]([CH3:22])[S:18]([CH3:21])(=[O:20])=[O:19])[N:4]2[N:3]=1.C(N(CC)C(C)C)(C)C.C1C=CC(N(S(C(F)(F)F)(=O)=O)S(C(F)(F)F)(=O)=O)=CC=1.C(OC([N:61]1[CH2:66][CH2:65][CH:64]([C:67]2[CH:72]=[CH:71][C:70]([NH2:73])=[C:69]([O:74][CH3:75])[CH:68]=2)[CH2:63][CH2:62]1)=O)(C)(C)C.C(Cl)Cl.FC(F)(F)C(O)=O>CN(C)C=O>[CH3:75][O:74][C:69]1[CH:68]=[C:67]([CH:64]2[CH2:63][CH2:62][NH:61][CH2:66][CH2:65]2)[CH:72]=[CH:71][C:70]=1[NH:73][C:2]1[N:7]=[CH:6][C:5]2=[C:8]([CH3:23])[CH:9]=[C:10]([C:11]3[CH:16]=[CH:15][CH:14]=[CH:13][C:12]=3[N:17]([CH3:22])[S:18]([CH3:21])(=[O:20])=[O:19])[N:4]2[N:3]=1Participants
Reactant 6
Product 1
Reagents, catalysts & solvents 1
Procedure
Into a 8-dram vial, N-[2-(2-Hydroxy-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-7-yl)-phenyl]-N-methyl-methanesulfonamide (210 mg, 0.63 mmol), N,N-Dimethylformamide (2.33 mL), N,N-Diisopropylethylamine (0.247 mL, 1.42 mmol), and N-Phenylbis(trifluoromethanesulphonimide) (0.276 g, 0.773 mmol) were added. The reaction was stirred at room temperature for 30 minutes. 4-(4-Amino-3-methoxy-phenyl)-piperidine-1-carboxylic acid tert-butyl ester (0.434 g, 1.42 mmol) was then added. The reaction mixture was heated at 120° C. for 4 hours. The solvent was removed under vacuum overnight. The resulting solid was treated with Methylene chloride (3.50 mL, 54.6 mmol) and Trifluoroacetic Acid (1.17 mL, 15.1 mmol) and stirred at room temperature overnight. The solvent was removed under vacuum. The reaction mixture was purified via HPLC reverse phase chromatography with 0.1% TFA in Water and 0.1% TFA in ACN. The collected fractions were lyophilized to give a yellow solid. The solid was partitioned with NaHCO3 and DCM. The organic was separated, washed with Brine and dried over Na2SO4. The solid was filtered and washed with DCM. The solvent was removed under vacuum to give N-{2-[2-(2-Methoxy-4-piperidin-4-yl-phenylamino)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-7-yl]-phenyl}-N-methyl-methanesulfonamide a yellow solid (0.135 g, 41%). LCMS (E/I+) 521.13 (M+H). NMR 1H (DMSO-d6)-8.96 (s, 1H), 8.47-8.62 (m, 1H), 8.15-8.33 (m, 1H), 7.88-8.00 (m, 2H), 7.46-7.68 (m, 4H), 6.84 (s , 1H), 6.82 (s, 1H), 6.66 (d, 1H, J=8.11 Hz), 3.86 (s, 3H), 3.39 (d, 2H, J=12.75), 3.07 (s, 3H), 2.90-3.04 (m, 2H), 2.88 (s, 3H), 2.72-2.84 (m, 1H), 1.95 (d, 2H, J=13.48 Hz), 1.68-1.84 (m, 2H).
Workup
- temperatureThe reaction mixture was heated at 120° C. for 4 hours
- customThe solvent was removed under vacuum overnight
- stirringstirred at room temperature overnight
- customThe solvent was removed under vacuum
- customThe reaction mixture was purified via HPLC reverse phase chromatography with 0.1% TFA in Water and 0.1% TFA in ACN
- customto give a yellow solid
- customThe solid was partitioned with NaHCO3 and DCM
- customThe organic was separated
- washwashed with Brine
- dry with materialdried over Na2SO4
- filtrationThe solid was filtered
- washwashed with DCM
- customThe solvent was removed under vacuum
Sources & evidence
- ORD record
- ord-9fb5aa1dac1c41b7b4c37b9d336014d4
- Source dataset
- uspto-grants-2013_06
- Patent number
- US08471005B2
Reaction notes
Loading…